Log In
BCIQ
Print this Print this
 

MSDC-0602

  Manage Alerts
Collapse Summary General Information
Company Metabolic Solutions Development Co.
DescriptionFollow-on mTOT modulating insulin sensitizer
Molecular Target Mitochondrial pyruvate carrier 1 (MPC1) (BRP44L) ; Mammalian target of rapamycin (mTOR) (FRAP) (RAFT1)
Mechanism of ActionMitochondrial target of thiazolidinedione (mTOT) modulator
Therapeutic ModalitySmall molecule

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today